Details of the Drug Formulations

General Information of Drug (ID: DM8V75C)

Drug Name
ABIRATERONE Drug Info
Synonyms Abiraterone (AR inhibitor)
Indication
Disease Entry ICD 11 Status REF
Prostate cancer 2C82.0 Approved [1]
Cross-matching ID
PubChem CID
132971
ChEBI ID
CHEBI:68642
CAS Number
154229-19-3
TTD ID
D02STN
ACDINA ID
D00004

Full List of Drug Formulations Containing This Drug

Abiraterone 250 mg tablet
Company Formulation ID FDA Description
Janssen Biotech F00019 Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Talc; Titanium dioxide; Water; Croscarmellose sodium; Polyethylene glycol 3350; Povidone k30; Silicon dioxide; Microcrystalline cellulose; Polyvinyl alcohol, unspecified
Janssen Biotech F00018 Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose; Povidone, unspecified
------------------------------------------------------------------------------------
Abiraterone 500 mg tablet
Company Formulation ID FDA Description
Janssen Biotech F00020 Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferric oxide red; Ferrosoferric oxide; Talc; Titanium dioxide; Water; Croscarmellose sodium; Polyethylene glycol 3350; Silicon dioxide; Hypromellose 2910 (15 mpa.s); Microcrystalline cellulose; Polyvinyl alcohol, unspecified
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6745).